Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] CPIP Roundup – April 30, 2020

Posted on: April 30, 2020May 13, 2026CPIP Roundup

Greetings from CPIP Executive Director Sean O’Connor As we move into another month of stay-at-home here in the DMV—and perhaps some re-openings—we here at CPIP hope that you and yours […]

[Archived Post] CPIP Welcomes Joshua Kresh as Deputy Director

Posted on: April 28, 2020May 13, 2026C-IP2 News

CPIP is proud to welcome Joshua Kresh to our leadership team! As Deputy Director, Joshua will report to CPIP Executive Director Sean O’Connor while managing and participating in CPIP’s day-to-day […]

[Archived Post] CPIP Bids a Fond Farewell to Kevin Madigan and Seeks New Deputy Director

Posted on: January 23, 2020May 13, 2026C-IP2 News

Longtime CPIP staff member Kevin Madigan is leaving the Center next week to become VP, Legal Policy and Copyright Counsel at the Copyright Alliance. “I joined CPIP just over four […]

[Archived Post] CPIP Roundup – August 29, 2019

Posted on: August 29, 2019May 13, 2026CPIP Roundup

Greetings from CPIP Executive Director Sean O’Connor With a new academic year beginning at Antonin Scalia Law School, the CPIP team continues to build on a productive summer of scholarship, […]

[Archived Post] “No Combination Drug Patents Act” Stalls, but Threats to Innovation Remain

Posted on: June 27, 2019May 13, 2026Biotech , Patents , Pharma

By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of […]

[Archived Post] CPIP Scholars Join Comment Letter to FTC Supporting Evidence-Based Approach to IP Policymaking

Posted on: January 7, 2019May 13, 2026FTC , Innovation

On December 21, 2018, CPIP Senior Scholars Jonathan Barnett, Chris Holman, Erika Lietzan, Adam Mossoff, Sean O’Connor, and Kristen Osenga joined a comment letter that was filed with the FTC […]

[Archived Post] Proposed Misuse of Section 1498 Relies on the False Claim that Patents Are Not Property

Posted on: November 14, 2018May 13, 2026Patent Law , Patent Theory

By Kathleen Wills* The question whether patents are property rights is a continuing and hotly debated topic in IP law. Despite an abundance of scholarship (see here, here, here, here, […]

[Archived Post] Proposal for Drug Price Controls is Legally Unprecedented and Threatens Medical Innovation

Posted on: November 5, 2018May 13, 2026Innovation , Patent Law

By Adam Mossoff, Sean O’Connor, & Evan Moore* The price of the miracle drugs everyone uses today is cause for concern among people today. The President has commented on it. […]

[Archived Post] CPIP Announces Leadership Transitions

Posted on: August 21, 2018May 13, 2026Press Release

ARLINGTON, Virginia – August 22, 2018 – The Center for the Protection of Intellectual Property (CPIP) announced today that Matthew Barblan, CPIP’s Executive Director, will leave the center this month […]

[Archived Post] Despite What You Hear, Notice and Takedown is Failing Creators and Copyright Owners

Posted on: August 24, 2016May 13, 2026Copyright , Copyright Licensing , Copyright Theory , Infringement , Intellectual Property Theory , Internet , Reasonable Royalty , Uncategorized

By Kevin Madigan In a recent op-ed in the LA Times, Professors Chris Sprigman and Mark Lemley praise the notice and takedown provisions of the Digital Millennium Copyright Act (DMCA) […]

Posts pagination

Previous page Page 1 Page 2 Page 3 Page 4 Next page

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes